SANFORD FRIEDMAN: Open Payments
NPI 1154335222 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,521 in 63 payments from 22 companies in 2025. Trend: 2023 $1,935 · 2024 $1,440 · 2025 $1,521
Food & beverage: $1,501Education: $20
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $242 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $178 |
| Novo Nordisk Inc | 6 | $178 |
| Novartis Pharmaceuticals Corporation | 11 | $164 |
| Madrigal Pharmaceuticals | 2 | $82 |
| Esperion Therapeutics, Inc. | 3 | $76 |
| AstraZeneca Pharmaceuticals LP | 3 | $73 |
| Amgen Inc. | 4 | $71 |
| Exact Sciences Corporation | 3 | $60 |
| Azurity Pharmaceuticals, Inc. | 2 | $56 |
Products named: JARDIANCE, Kerendia, LEQVIO, Wegovy, Ozempic, REZDIFFRA, NEXLETOL, REPATHA.
Industry payments across NY — which companies pay providers there.
